AU Stock MarketDetailed Quotes
PER Percheron Therapeutics Ltd
- 0.074
- +0.003+4.23%
20min DelayNot Open Nov 28 16:00 AET
80.47MMarket Cap-5285P/E (Static)
0.075High0.073Low1.66MVolume0.073Open0.071Pre Close123.03KTurnover0.14052wk High0.21%Turnover Ratio1.09BShares0.05652wk Low-0.014EPS TTM58.48MFloat Cap0.140Historical HighLossP/E (Static)790.31MShs Float0.056Historical Low-0.014EPS LYR2.82%Amplitude--Dividend TTM8.22P/B1Lot Size--Div YieldTTM
About Percheron Therapeutics Ltd Company
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Company Profile
SymbolPER
Company NamePercheron Therapeutics Ltd
Founded2000
MarketASX
Employees3
Fiscal Year Ends06-30
Address14 Wallace Avenue LEVEL 1
CityToorak
CountryAustralia
Zip Code3142
Phone+61 398278999
Websitehttps://www.percherontx.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- James Garner
- Chief Executive Officer,Managing Director
- --
- Charmaine Gittleson
- Executive Chairman,Executive Director
- --
- Ben Gil Price
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data